| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/25/2004 | US20040058910 Drug abuse, alcoholism, tobacco |
| 03/25/2004 | US20040058909 Method of treatment |
| 03/25/2004 | US20040058907 Compounds useful in the treatment of inflammatory diseases |
| 03/25/2004 | US20040058906 Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders |
| 03/25/2004 | US20040058904 Antiinflammatory agents; autoimmune disease |
| 03/25/2004 | US20040058900 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 03/25/2004 | US20040058869 Methods and reagents for modulating cholesterol levels |
| 03/25/2004 | US20040058850 Using caspase inhibitor; antiinflammatory agents |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | US20040058414 Preparing antibody capable of binding and inhibiting activity of interleukin-2 and receptor, herpes viral epitopes and interferon receptors; diagnosis and treatment of viral and autoimmune diseases |
| 03/25/2004 | US20040058367 Comprises interleukin 1b converting enzyme inhibitor for diagnosis, prevention and treatment of viral, nervous system, ischemic and graft-versus-host diseases |
| 03/25/2004 | US20040058366 Comprises DNA coding brain-muscle-arnt-like protein 2 (BMAL2) for diagnosis and treatment of circadian rythm disorders |
| 03/25/2004 | US20040058353 Comprises nucleotide sequences coding transport proteins for diagnosis and treatment of pain, psychotic, eating and nervous system disorders |
| 03/25/2004 | US20040058019 Kit and method for migraine headache treatment |
| 03/25/2004 | US20040058016 Lower alcohol-insoluble extract of hovenia dulcis var koreana nakai, a polysaccharide isolated therefrom and an antihepatotoxic composition containing same |
| 03/25/2004 | US20040057964 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 03/25/2004 | US20040057943 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 03/25/2004 | US20040057928 Use of IL-6R/IL-6 chimera, a mutein, isoform, fused protein, functional derivative, active fraction or circularly permutated derivative or a salt thereof, for manufacture of medicament for therapy and/or prophylaxis |
| 03/25/2004 | US20040056240 Adhesive |
| 03/25/2004 | CA2499142A1 Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia |
| 03/25/2004 | CA2498777A1 Non-sequence complementary antiviral oligonucleotides |
| 03/25/2004 | CA2498269A1 Substituted aminoethers for the treatment of alzheimer's disease |
| 03/25/2004 | CA2498260A1 Pharmaceutical formulations of modafinil |
| 03/25/2004 | CA2498175A1 Treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine |
| 03/25/2004 | CA2498131A1 Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans |
| 03/25/2004 | CA2498010A1 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan |
| 03/25/2004 | CA2497783A1 Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans |
| 03/25/2004 | CA2497214A1 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines |
| 03/25/2004 | CA2497078A1 2-pyrrolidin-2-yl-[1,3,4]-oxadiazole derivatives and the use of the same as antidepressants |
| 03/25/2004 | CA2497067A1 Amino-propanol derivatives |
| 03/25/2004 | CA2494975A1 Substituted 1,4-pyrazine derivatives |
| 03/24/2004 | EP1400576A1 Adhesive |
| 03/24/2004 | EP1399744A2 Epf receptor assays, compounds and therapeutic compositions |
| 03/24/2004 | EP1399570A2 Peptides for use as translocation factors |
| 03/24/2004 | EP1399558A2 Vanilloid receptor-related nucleic acids and polypeptides |
| 03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
| 03/24/2004 | EP1399548A2 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 03/24/2004 | EP1399537A2 Therapeutic polypeptides, nucleic acids encoding same and methods of use |
| 03/24/2004 | EP1399479A2 Cation conducting gaba a receptors and their use |
| 03/24/2004 | EP1399471A2 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders |
| 03/24/2004 | EP1399450A1 Benzoxazepine derivatives and their use as ampa receptor stimulators |
| 03/24/2004 | EP1399449A1 Carbohydrate derivatives |
| 03/24/2004 | EP1399448A1 Imidazo 1,5-a] pyrimido 5,4-d] benzazepine derivatives as gaba a receptor modulators |
| 03/24/2004 | EP1399446A1 2,6,9-substituted purine derivatives and their use in the treatment of proliferative disorders |
| 03/24/2004 | EP1399445A2 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 03/24/2004 | EP1399441A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/24/2004 | EP1399440A1 5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase inhibitors |
| 03/24/2004 | EP1399439A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 03/24/2004 | EP1399438A1 Novel heteroaryl derivatives, their preparation and use |
| 03/24/2004 | EP1399435A2 Pyridine derivatives useful as cd40:cd154 binding interruptors and use thereof to treat immunological complications |
| 03/24/2004 | EP1399434A1 Novel indole derivatives |
| 03/24/2004 | EP1399433A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 03/24/2004 | EP1399432A1 Spiropiperidine compounds as ligands for orl-1 receptor |
| 03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 03/24/2004 | EP1399430A1 Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor |
| 03/24/2004 | EP1399428A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators |
| 03/24/2004 | EP1399426A2 Compounds, compositions and methods for modulating beta-amyloid production |
| 03/24/2004 | EP1399424A1 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide |
| 03/24/2004 | EP1399420A2 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 03/24/2004 | EP1399419A1 New compounds useful in reflux disease |
| 03/24/2004 | EP1399406A2 Novel estrogen receptor ligands and methods i |
| 03/24/2004 | EP1399206A2 Hydrophobic dopamine agonists administered to the dermis |
| 03/24/2004 | EP1399205A2 Enhanced systemic absorption of intradermally delivered substances |
| 03/24/2004 | EP1399167A1 Arylazo-substituted imidazole for the treatment of stress urinary incontinence |
| 03/24/2004 | EP1399165A2 Stabilized dispersion of phytosterol in oil |
| 03/24/2004 | EP1399162A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
| 03/24/2004 | EP1399161A2 Sustained-release analgesic compounds |
| 03/24/2004 | EP1399160A2 Nr2b receptor antagonists for the treatment or prevention of migraines |
| 03/24/2004 | EP1399157A1 Combination comprising a p-gp inhibitor and an anti-epileptic drug |
| 03/24/2004 | EP1399155A2 Small molecules useful in the treatment of inflammatory disease |
| 03/24/2004 | EP1399151A2 A method for treating inflammatory diseases by administering a ppar-delta agonist |
| 03/24/2004 | EP1399147A2 Therapeutic delivery of carbon monoxide |
| 03/24/2004 | EP1399144A1 Carbamate compounds for use in preventing or treating anxiety disorders |
| 03/24/2004 | EP1399143A1 Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia |
| 03/24/2004 | EP1399141A1 Use of acetyl l-carnitine for the preparation of a medication for the preventive therapy for pain |
| 03/24/2004 | EP1399137A1 Sulfonamides |
| 03/24/2004 | EP1349558A4 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 03/24/2004 | EP1303517B1 Indoloquinazolinones |
| 03/24/2004 | EP1299384B1 Indole derivatives useful for the treatment of cns disorders |
| 03/24/2004 | EP1292606A4 Positively-charged peptide nucleic acid analogs with improved properties |
| 03/24/2004 | EP1242087B1 Analgesic compositions containing buprenorphine |
| 03/24/2004 | EP1214296B1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/24/2004 | EP1212119B1 USE OF CYAMEMAZINE FOR the treatment of abrupt benzodiazepine withdrawal |
| 03/24/2004 | EP1161232B1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 03/24/2004 | EP1143964B1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission |
| 03/24/2004 | EP1140895B1 Thiopyran compounds as inhibitors of mmp |
| 03/24/2004 | EP1124809B1 Benzoylpyridazines |
| 03/24/2004 | EP1115415B1 Use of gnrh analogues in the treatment of schizophrenia |
| 03/24/2004 | EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/24/2004 | EP1047690B1 Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission |
| 03/24/2004 | EP1003505B1 Heterocyclic vinylethers against neurological disorders |
| 03/24/2004 | CN1484652A Antibodies to human IL-1 beta |
| 03/24/2004 | CN1484650A Urocortin proteins and uses thereof |
| 03/24/2004 | CN1484644A Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/24/2004 | CN1484642A Excitatory amino acid receptor antagonists |
| 03/24/2004 | CN1484640A Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 03/24/2004 | CN1484638A I-aryl-or-I-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-b ligands |
| 03/24/2004 | CN1484633A N (phenylsulphonyl) glycine derivatives and their therapentic use |
| 03/24/2004 | CN1484527A Medicines for treatment and prevention of neurogenic pain |
| 03/24/2004 | CN1484526A Perturbed membrane-binding compounds |